Retatrutide (60mg)
Triple GLP-1/GIP/glucagon receptor agonist researched for metabolic regulation.
Product Details
| Product | Retatrutide (60mg) |
|---|
| Size | 60mg |
|---|
| Category | Metabolic & Appetite Research |
|---|
| Price | 90.00 USD |
|---|
| Availability | In Stock |
|---|
| Purity | ≥99% (third-party tested) |
|---|
| CAS Number | 2381089-83-2 |
|---|
| Molecular Weight | 4604.14 g/mol |
|---|
| Form | Lyophilized powder (vial) |
|---|
| Storage | Refrigerate at 2–8°C after reconstitution |
|---|
| Brand | Helix Amino |
|---|
Research Notes
Preclinical and early clinical research has demonstrated triple incretin receptor agonism producing potent effects on body weight, glycemic control, and energy expenditure. The addition of glucagon receptor activation enhances thermogenesis and lipid oxidation beyond dual agonists. Studies show significant improvements in metabolic endpoints.
View Certificate of Analysis (COA) · View Safety Data Sheet (SDS)
Disclaimer: All products are for in-vitro laboratory research use only. Not for human consumption. Not evaluated or approved by the FDA.